Myotonic Dystrophies

被引：1
|
作者：
Schneider-Gold, C. [1 ]
Grimm, T. [2 ]
Kress, W. [2 ]
Schoser, B. [3 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, D-44807 Bochum, Germany
[2] Univ Wurzburg, Inst Humangenet, D-97070 Wurzburg, Germany
[3] Univ Munich, Friedrich Baur Inst, D-80539 Munich, Germany
来源：
AKTUELLE NEUROLOGIE | 2010年 / 37卷 / 07期
关键词：
CREATINE MONOHYDRATE; DOUBLE-BLIND; TYPE-2; ABNORMALITIES; EXPANSION; STRENGTH; THERAPY; DEATH;
D O I：
10.1055/s-0030-1248592
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：348 / 356
页数：9
相关论文
共 50 条
  • [11] Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy
    Rimoldi, Martina
    Lucchiari, Sabrina
    Pagliarani, Serena
    Meola, Giovanni
    Comi, Giacomo Pietro
    Abati, Elena
    NEUROLOGICAL SCIENCES, 2024, : 1599 - 1616
  • [12] Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?
    Stahl, K.
    Wenninger, S.
    Schueller, A.
    Montagnese, F.
    Schoser, B.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 (04) : 211 - 216
  • [13] Association of peripheral neuropathy with sleep- related breathing disorders in myotonic dystrophies
    Banach, Marta
    Antczak, Jakub
    Rola, Rafal
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 133 - 140
  • [14] Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
    Gliem, Carla
    Minnerop, Martina
    Roeske, Sandra
    Gaertner, Hanna
    Schoene-Bake, Jan-Christoph
    Adler, Sandra
    Witt, Juri-Alexander
    Hoffstaedter, Felix
    Schneider-Gold, Christiane
    Betz, Regina C.
    Helmstaedter, Christoph
    Tittgemeyer, Marc
    Amunts, Katrin
    Klockgether, Thomas
    Weber, Bernd
    Kornblum, Cornelia
    PLOS ONE, 2019, 14 (03):
  • [15] The Role of Flexibility in the Rational Design of Modularly Assembled Ligands Targeting the RNAs that Cause the Myotonic Dystrophies
    Disney, Matthew D.
    Lee, Melissa M.
    Pushechnikov, Alexei
    Childs-Disney, Jessica L.
    CHEMBIOCHEM, 2010, 11 (03) : 375 - 382
  • [16] Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2
    Wenninger, Stephan
    Stahl, Kristina
    Montagnese, Federica
    Schoser, Benedikt
    EUROPEAN NEUROLOGY, 2020, 83 (05) : 523 - 533
  • [17] Upgrading molecular diagnostics of myotonic dystrophies: Multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs
    Radvansky, Jan
    Ficek, Andrej
    Kadasi, Ludevit
    MOLECULAR AND CELLULAR PROBES, 2011, 25 (04) : 182 - 185
  • [18] Myotonic dystrophy: diagnosis, management and new therapies
    Turner, Chris
    Hilton-Jones, David
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (05) : 599 - 606
  • [19] Update on Therapy for Myotonic Dystrophy Type 1
    Ivanovic, Vukan
    Meola, Giovani
    Vukojevic, Zoran
    Peric, Stojan
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2023, 25 (08) : 261 - 279
  • [20] Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
    Bachinski, Linda L.
    Baggerly, Keith A.
    Neubauer, Valerie L.
    Nixon, Tamara J.
    Raheem, Olayinka
    Sirito, Mario
    Unruh, Anna K.
    Zhang, Jiexin
    Nagarajan, Lalitha
    Timchenko, Lubov T.
    Bassez, Guillaume
    Eymard, Bruno
    Gamez, Josep
    Ashizawa, Tetsuo
    Mendell, Jerry R.
    Udd, Bjame
    Krahe, Ralf
    NEUROMUSCULAR DISORDERS, 2014, 24 (03) : 227 - 240
12345